MicroRNAs in T Cell-Immunotherapy
MicroRNAs (miRNAs) act as master regulators of gene expression in homeostasis and disease. Despite the rapidly growing body of evidence on the theranostic potential of restoring miRNA levels in pre-clinical models, the translation into clinics remains limited. Here, we review the current knowledge o...
Main Authors: | Sara G. Dosil, Ana Rodríguez-Galán, Francisco Sánchez-Madrid, Lola Fernández-Messina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/1/250 |
Similar Items
-
Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis
by: Chiara Tupini, et al.
Published: (2023-04-01) -
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
by: Neha Datta, et al.
Published: (2023-08-01) -
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
by: Chia-Hsin Liu, et al.
Published: (2022-01-01) -
Delivery of AntagomiR-7 through polymer nanoparticles for assisting B Cell to alleviate systemic lupus erythematosus
by: Hui Guo, et al.
Published: (2023-04-01) -
Use of AgomiR and AntagomiR technologies to alter satellite cell proliferation in vitro, miRNA expression, and muscle fiber hypertrophy in intrauterine growth-restricted lambs
by: M. A. Greene, et al.
Published: (2023-11-01)